Mobile

A randomized, open label comparative study to determine the proportion of asthma patients on Seretide Diskus 50/250 mcg b.i.d. achieving total control when given medication and compli-ance enhancement...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-000374-48

A randomized, open label comparative study to determine the proportion of asthma patients on Seretide Diskus 50/250 mcg b.i.d. achieving total control when given medication and compli-ance enhancement training compared to those receiving medica-tion only

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the proportion of asthma subjects achieving Total control of their asthma in 7 weeks out of the last 8 consecutive weeks of treatment period 2 when given Seretide Diskus 50/250 mcg b.i.d with compliance enhancement training compared to those given medication alone.

Critère d'inclusion

  • Asthma

Liens